WELLS FARGO & COMPANY/MN - BIONDVAX PHARMACEUTICALS LTD ownership

BIONDVAX PHARMACEUTICALS LTD's ticker is BVXV and the CUSIP is 09073Q105. A total of 9 filers reported holding BIONDVAX PHARMACEUTICALS LTD in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of BIONDVAX PHARMACEUTICALS LTD
ValueSharesWeighting
Q3 2022$02000.0%0.00%
Q2 2022$02000.0%0.00%
Q1 2022$02000.0%0.00%
Q4 2021$0
-100.0%
200
-41.5%
0.00%
Q3 2021$1,0000.0%3420.0%0.00%
Q2 2021$1,000
-66.7%
342
-62.3%
0.00%
Q1 2021$3,000
-40.0%
908
-46.6%
0.00%
Q4 2020$5,000
-96.6%
1,699
-54.8%
0.00%
Q3 2020$147,000
+444.4%
3,763
+220.5%
0.00%
Q2 2020$27,000
+285.7%
1,174
+34.3%
0.00%
Q1 2020$7,000
-12.5%
8740.0%0.00%
Q4 2019$8,000
+60.0%
8740.0%0.00%
Q3 2019$5,0000.0%8740.0%0.00%
Q2 2019$5,0000.0%8740.0%0.00%
Q1 2019$5,000
+25.0%
8740.0%0.00%
Q4 2018$4,000
-20.0%
8740.0%0.00%
Q3 2018$5,000
-16.7%
8740.0%0.00%
Q2 2018$6,000
+20.0%
8740.0%0.00%
Q1 2018$5,0000.0%874
-12.6%
0.00%
Q4 2017$5,000
-28.6%
1,0000.0%0.00%
Q3 2017$7,000
+16.7%
1,000
+42.9%
0.00%
Q2 2017$6,0007000.00%
Other shareholders
BIONDVAX PHARMACEUTICALS LTD shareholders Q3 2019
NameSharesValueWeighting ↓
TRUE Private Wealth Advisors 55,500$64,0000.01%
Aspire Private Capital, LLC 1,600$2,0000.00%
ROYAL BANK OF CANADA 2,540$3,0000.00%
UBS Group AG 4,692$5,0000.00%
CREDIT AGRICOLE S A 4,240$5,0000.00%
WELLS FARGO & COMPANY/MN 200$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 13,768$16,0000.00%
MORGAN STANLEY 33,281$39,0000.00%
Renaissance Technologies 18,300$21,0000.00%
View complete list of BIONDVAX PHARMACEUTICALS LTD shareholders